DepoMed, Inc. (DEPO) Tops Q1 EPS by 20c

DepoMed, Inc. (NASDAQ: DEPO) reported Q1 EPS of $0.30, $0.20 better than the analyst estimate of $0.10. Revenue for the quarter came in at $76.54 million versus the consensus estimate of $53.57 million.

For earnings history and earnings-related data on DepoMed, Inc. (DEPO) click here.

You May Also Be Interested In

• SanDisk and Micron surge as Apple confirms memory price pass-through
• FedEx (FDX) PT Lowered to $424 at Bernstein SocGen Group
• Citi sees this stock as primary lithium demand beneficiary, upgrades to Buy